Syros Pharmaceuticals Obtains $53,149,996 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0546dddc-4442-4227-9a82-f46086eb06d9
Date
10/27/2014
Company Name
Syros Pharmaceuticals
Mailing Address
480 Arsenal Street Watertown, MA 02472 USA
Company Description
Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities.
Website
http://www.syros.com
Transaction Type
Venture Equity
Transaction Amount
$53,149,996
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor